LAZ.NYSELazard, INC

Form 4: Lazard CEO Peter Orszag Executes Stock Transactions Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Lazard CEO Peter Orszag reports the exchange of performance-based restricted participation units (PRPUs) for common stock and subsequent sales under a pre-arranged 10b5-1 trading plan to cover taxes and personal expenditures.

Summary

  • Peter Orszag, CEO and Chairman of Lazard, Inc., reported transactions involving Lazard's common stock.
  • On March 13, 2025, Orszag exchanged 258,154 performance-based restricted participation units (PRPUs) for 258,154 shares of common stock.
  • Also on March 13, 2025, 77,446 shares were sold to the company at $45.09 to cover estimated taxes.
  • Subsequent sales of common stock occurred on March 14 and March 17, 2025, under a Rule 10b5-1 trading plan.
  • These sales were intended to cover estimated taxes and other personal expenditures.
  • The sales prices ranged from $44.31 to $46.11 per share.
  • Orszag also acquired 168,206 Restricted Participation Units (RPUs) on March 14, 2025, which will vest around March 15, 2027.

Sentiment

Score: 6

Explanation: The document reflects routine transactions by a company executive. While the sales might exert some downward pressure on the stock, the pre-planned nature mitigates significant concern.

Future Outlook

The document indicates ongoing sales of shares under a pre-arranged 10b5-1 trading plan, suggesting continued transactions in the near term.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of 10b5-1 plans is a common practice to allow insiders to sell shares while avoiding accusations of trading on non-public information.

Comparison to Industry Standards

  • The transactions are typical for executives at publicly traded companies.
  • The use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations, similar to practices at companies like Goldman Sachs or Morgan Stanley.
  • The vesting schedule of the Restricted Participation Units is also a common incentive mechanism used across the financial industry.

Stakeholder Impact

  • Shareholders may experience slight dilution from the issuance of shares related to the PRPUs.
  • The sales under the 10b5-1 plan could exert minor downward pressure on the stock price in the short term.

Key Dates

DateDescription
2024-12-13Date of adoption of Rule 10b5-1 trading plan
2025-03-13Exchange of Performance-based Restricted Participation Units (PRPUs) for Common Stock
2025-03-13Sale of Common Stock to cover estimated taxes
2025-03-14Sale of Common Stock under Rule 10b5-1 trading plan
2025-03-14Acquisition of Restricted Participation Units (RPUs)
2025-03-17Sale of Common Stock under Rule 10b5-1 trading plan
2027-03-15Vesting date of Restricted Participation Units (RPUs)

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.